Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Breast Cancer 2024

Gilead - Experts debate: Navigating the complexities of metastatic breast cancer treatment

Debate topic: How would you sequence ADCs for patients with pretreated HR+/HER2- metastatic breast cancer?

Date

16 May 2024

Session

Gilead - Experts debate: Navigating the complexities of metastatic breast cancer treatment

Presenters

Diana Luftner

Authors

D.I. Luftner1, S.M. Tolaney2

Author affiliations

  • 1 MHB - Brandenburg Medical School Theodor Fontane - Institute of Social Medicine and Epidemiology, Brandenburg an der Havel/DE
  • 2 Dana Farber Cancer Institute, Boston/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Javier Cortes

Session: Gilead - Experts debate: Navigating the complexities of metastatic breast cancer treatment

Resources:

Webcast

Q&A / discussion

Session: Gilead - Experts debate: Navigating the complexities of metastatic breast cancer treatment

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.